| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/09537104.2011.553970 |
| P698 | PubMed publication ID | 21438846 |
| P2093 | author name string | Michihiko Miyaji | |
| Tomoki Ito | |||
| Shinichiro Mori | |||
| Shinya Fujita | |||
| Shosaku Nomura | |||
| Kazuyoshi Ishii | |||
| Ryotaro Ozasa | |||
| Takahisa Nakanishi | |||
| P433 | issue | 5 | |
| P921 | main subject | disseminated intravascular coagulation | Q823027 |
| P304 | page(s) | 396-397 | |
| P577 | publication date | 2011-03-26 | |
| P1433 | published in | Platelets | Q1573582 |
| P1476 | title | The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy | |
| P478 | volume | 22 |
| Q33676193 | Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET |
| Q39151877 | Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review |
| Q26830846 | Clinical significance of procoagulant microparticles |
| Q39107240 | Extracellular vesicles and blood diseases |
| Q49630769 | From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis |
| Q36335907 | Platelet-derived HMGB1 is a critical mediator of thrombosis. |
| Q35073017 | RETRACTED: Correlation between serum levels of high mobility group box-1 protein and pancreatitis: a meta-analysis |
| Q58083422 | Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia |
Search more.